Contera Pharma Email Format
Biotechnology ResearchHovedstaden, Denmark11-50 Employees
Contera Pharma is a Denmark-based biotechnology company focused on discovering and developing therapies for neurological disorders. The organization aims to improve the lives of people affected by these conditions through innovative treatment approaches. Based in Hørsholm in the Capital Region, it operates as a small to mid-sized firm within the biotechnology research sector, concentrating on neurological disease research and development. In 2024, the company announced leadership changes, including the appointment of a Chief Medical Officer. It also closed its Korea office to consolidate activities at its Danish headquarters. Historically, Contera Pharma has pursued partnerships and collaborations to advance neurological disease programs, including efforts related to Parkinson's disease and nucleic acid–based therapies.